Roche has announced that it will be advancing its Prothena-partnered investigational Parkinson’s disease (PD) drug ...

Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

A schematic diagram of the development of next-generation RNA gene editing technology using induction evolution The Catholic ...

Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...

Roche and Prothena are forging ahead to late-stage studies for their investigational Parkinson’s disease antibody ...

Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today its decision to proceed with Phase III ...

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion therapy, a cutting-edge ...

A team of researchers at UCLA has developed a high-tech diagnostic pen that can detect signs of Parkinson’s disease with over ...

Morten Harket, the beloved front man of the pop-synth group A-ha, shared some heartbreaking health news with fans recently in ...

Morten Harket, frontman of the Norwegian ’80s new wave band A-ha, has Parkinson’s disease. Harket opens up about his ...